146 related articles for article (PubMed ID: 15324885)
1. Exploring QSAR with E-state index: selectivity requirements for COX-2 versus COX-1 binding of terphenyl methyl sulfones and sulfonamides.
Chakraborty S; Sengupta C; Roy K
Bioorg Med Chem Lett; 2004 Sep; 14(18):4665-70. PubMed ID: 15324885
[TBL] [Abstract][Full Text] [Related]
2. Comparative QSAR modeling of COX-2 inhibitor 1,2-diarylimidazoles using E-state and physicochemical parameters.
Chakraborty S; Sengupta C; Roy K
Indian J Biochem Biophys; 2007 Jun; 44(3):169-75. PubMed ID: 17650586
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
[TBL] [Abstract][Full Text] [Related]
4. Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents.
Li JJ; Norton MB; Reinhard EJ; Anderson GD; Gregory SA; Isakson PC; Koboldt CM; Masferrer JL; Perkins WE; Seibert K; Zhang Y; Zweifel BS; Reitz DB
J Med Chem; 1996 Apr; 39(9):1846-56. PubMed ID: 8627608
[TBL] [Abstract][Full Text] [Related]
5. QSAR studies on structurally similar 2-(4-methanesulfonylphenyl)pyran-4-ones as selective COX-2 inhibitors: a Hansch approach.
Prasanna S; Manivannan E; Chaturvedi SC
Bioorg Med Chem Lett; 2005 Jan; 15(2):313-20. PubMed ID: 15603946
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 1,3-diphenylprop-2-en-1-ones possessing a methanesulfonamido or an azido pharmacophore as cyclooxygenase-1/-2 inhibitors.
Zarghi A; Zebardast T; Hakimion F; Shirazi FH; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Oct; 14(20):7044-50. PubMed ID: 16798002
[TBL] [Abstract][Full Text] [Related]
7. Theoretical studies on the inhibition mechanism of cyclooxygenase-2. Is there a unique recognition site?
Soliva R; Almansa C; Kalko SG; Luque FJ; Orozco M
J Med Chem; 2003 Apr; 46(8):1372-82. PubMed ID: 12672237
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and structure-activity relationship studies of 3,4,6-triphenylpyran-2-ones as selective cyclooxygenase-2 inhibitors.
Rao PN; Uddin MJ; Knaus EE
J Med Chem; 2004 Jul; 47(16):3972-90. PubMed ID: 15267236
[TBL] [Abstract][Full Text] [Related]
9. Sulfonamido, azidosulfonyl and N-acetylsulfonamido analogues of rofecoxib: 4-[4-(N-acetylsulfonamido)phenyl]-3-(4-methanesulfonylphenyl)-2(5H)furanone is a potent and selective cyclooxygenase-2 inhibitor.
Zarghi A; Praveen Rao PN; Knaus EE
Bioorg Med Chem Lett; 2004 Apr; 14(8):1957-60. PubMed ID: 15050636
[TBL] [Abstract][Full Text] [Related]
10. A CoMFA study of COX-2 inhibitors with receptor based alignment.
Datar PA; Coutinho EC
J Mol Graph Model; 2004 Dec; 23(3):239-51. PubMed ID: 15530820
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents.
Velázquez C; Rao PN; McDonald R; Knaus EE
Bioorg Med Chem; 2005 Apr; 13(8):2749-57. PubMed ID: 15781386
[TBL] [Abstract][Full Text] [Related]
12. QSAR analyses of conformationally restricted 1,5-diaryl pyrazoles as selective COX-2 inhibitors: application of connection table representation of ligands.
Prasanna S; Manivannan E; Chaturvedi SC
Bioorg Med Chem Lett; 2005 Apr; 15(8):2097-102. PubMed ID: 15808476
[TBL] [Abstract][Full Text] [Related]
13. Partially unified multiple property recursive partitioning (PUMP-RP) analyses of cyclooxygenase (COX) inhibitors.
Rao SN; Stockfisch TP
J Chem Inf Comput Sci; 2003; 43(5):1614-22. PubMed ID: 14502496
[TBL] [Abstract][Full Text] [Related]
14. Interactions of some PGHS-2 selective inhibitors with the PGHS-1: an automated docking study by BioDock.
Pedretti A; Villa AM; Villa L; Vistoli G
Farmaco; 1997; 52(6-7):487-91. PubMed ID: 9372601
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of N-acetyl-2-carboxybenzenesulfonamides: a novel class of cyclooxygenase-2 (COX-2) inhibitors.
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2005 Apr; 13(7):2459-68. PubMed ID: 15755648
[TBL] [Abstract][Full Text] [Related]
16. QSAR of estrogen receptor modulators: exploring selectivity requirements for ER(alpha) versus ER(beta) binding of tetrahydroisoquinoline derivatives using E-state and physicochemical parameters.
Mukherjee S; Saha A; Roy K
Bioorg Med Chem Lett; 2005 Feb; 15(4):957-61. PubMed ID: 15686893
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of linear phenylethynylbenzenesulfonamide regioisomers as cyclooxygenase-1/-2 (COX-1/-2) inhibitors.
Anana R; Rao PN; Chen QH; Knaus EE
Bioorg Med Chem; 2006 Aug; 14(15):5259-65. PubMed ID: 16635574
[TBL] [Abstract][Full Text] [Related]
18. Exploring selectivity requirements for COX-2 versus COX-1 binding of 3,4-diaryloxazolones using E-state index.
Roy K; Chakraborty S; Saha A
Bioorg Med Chem Lett; 2003 Nov; 13(21):3753-7. PubMed ID: 14552773
[TBL] [Abstract][Full Text] [Related]
19. Methanesulfonamide group at position-4 of the C-5-phenyl ring of 1,5-diarylpyrazole affords a potent class of cyclooxygenase-2 (COX-2) inhibitors.
Singh SK; Vobbalareddy S; Shivaramakrishna S; Krishnamraju A; Rajjak SA; Casturi SR; Akhila V; Rao YK
Bioorg Med Chem Lett; 2004 Apr; 14(7):1683-8. PubMed ID: 15026050
[TBL] [Abstract][Full Text] [Related]
20. Exploring selectivity requirements for COX-2 versus COX-1 binding of 2-(5-phenyl-pyrazol-1-yl)-5-methanesulfonylpyridines using topological and physico-chemical parameters.
Chakraborty S; Sengupta C; Roy K
Indian J Biochem Biophys; 2005 Apr; 42(2):106-12. PubMed ID: 23923570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
